BRIAN A. JACKSON, District Judge.
Before the Court is Quality Toxicology, LLC's ("Defendant")
This matter arises out of circumstances which have been previously set forth in the Court's Order addressing Plaintiff's Motion for Partial Summary Judgment (Doc. 76). In short, Plaintiff claimed that Defendant breached contracts relating to several business agreements for the referral and testing of urine samples. (Doc. 76). At the trial, the jury returned a verdict in favor of Plaintiff, and awarded damages in the amount of $635,032.23 and $269,706.50 for breaches of contractual obligations. (Doc. 105).
Federal Rule of Civil Procedure 59(a)(1)(A) provides that the court "may, on motion, grant a new trial on all or some of the issues — and to any party — ... after a jury trial, for any reason for which a new trial has heretofore been granted in an action at law in federal court." Fed. R. Civ. P. 59(a)(1)(A). "The decision to grant or deny a motion for new trial is within the sound discretion of the trial court ..." Pryor v. Trane Co., 138 F.3d 1024, 1026 (5th Cir. 1998).
Defendant claims that this Court erred when it declined to allow the jury to consider the testimony of John McFadden. (Doc. 133-1 at par. 1). The Court barred any mention during trial of Toxnet Diagnostic Laboratories ("Toxnet"), which is alleged to be a company started by current employees of Acadian Diagnostic Laboratories, LLC and prior employees of Quality Toxicology, LLC. (Doc. 97 at pp. 4-5). The Court reasoned that the mention of Toxnet would be unduly prejudicial to Plaintiff, and a waste of time under Fed. R. Evid. 403. (Id. at p. 5).
The Court heard McFadden's proffered testimony, the subject of which was Toxnet, and the circumstances surrounding its creation. (Doc. 114). Despite Defendant's request, the Court declined to reconsider its prior ruling on the admissibility of evidence relating to Toxnet. (Id. at p. 14).
The grant or denial of a motion in limine is fully within the discretion of the trial Court. Hesling v. CSX Transp., Inc., 396 F.3d 632, 643 (5th Cir. 2005). Having found that the proffered testimony pertained to Toxnet, the Court declined to allow McFadden to testify. Defendant offered no further justification for the admission of testimony, which covered topics previously barred by the Court's ruling on Plaintiff's motion in limine. (Doc. 97). Plaintiff's request for a new trial based on the exclusion of McFadden's proffered testimony is DENIED.
Defendant next claims that the Court misrepresented certain statements as "established facts" when it instructed the jury that Plaintiff referred urine samples to Defendant in 2013. (Doc. 113 at p. 103). Defendant claims that the testimony of Kevin Hanley, owner of Acadian Diagnostic Laboratories, LLC, directly contradicted this statement. (Id.).
This argument lacks merit. Presumably after reviewing the evidence and the proposed testimony of Hanley, the parties submitted a document titled "Proposed Joint Jury Instructions, Jury Interrogatories, Verdict Form and Special Voir Dire." (Doc. 87) (emphasis added). In this joint filing, under the title "Summary of the Court's Prior Rulings on Plaintiff's Claims," the parties submitted:
The parties themselves claimed it was an established fact that payments were collected on the Acadian Referred Specimens, indicating that specimens were in fact referred to Defendant. Furthermore, the parties acknowledged that such information was already the subject of the Court's prior ruling. (Id.). Finally, prior to the instructions being presented to the jury, the Court discussed the proposed jury instructions and solicited objections. (Doc. 113 at pp. 101-105). Having heard Defendant's objections to various portions of the jury instructions, the Court declined to re-charge the jury. Given the joint submissions provided by the parties (Doc. 87 at p. 6), the Court finds that the jury instructions were appropriate. Defendant's request for a new trial based on the content of the Court's instructions to the jury is DENIED.
Finally, Plaintiff claims that there were certain terms that should have been defined on the jury verdict form. The Court directed the parties to supply a joint verdict form. (Doc. 18). Both parties reviewed the language of the jury verdict form when it was prepared. At no point prior to the form's submission to the jury did Defendant request that it be amended to add clarity or specificity regarding certain terms. This issue should have been addressed prior to jury deliberations. It was not, and the Court will not now alter what the parties had ample opportunity to fix prior to the submission of the form to the jury.
Accordingly,